Idorsia aims to be Europe’s leading biopharmaceutical company, with a strong scientific core. We provide regular updates on the progress being made towards this goal. This section of the website provides journalists with additional material to support the generation of articles.
News
| 28 Jul 2021 | |
| 28 Jul 2021 | |
| 20 Jul 2021 |
Events
| Event | When |
| J.P. Morgan Healthcare Conference |
Press release |
| Nine-months 2021 Financial Results reporting* | October 26, 2021 |
| Credit Suisse Annual Healthcare Conference | November 8-11, 2021 |
| Jefferies Global Healthcare Conference | November 16-18, 2021 |
| Credit Suisse Equity Forum | November 16-19, 2021 |
| Evercore ISI HealthCONx Conference | November 30-December 2, 2021 |
| Full-Year 2021 Financial Results reporting* | February 8, 2022 |
|
First-Quarter 2022 Financial Results reporting*
|
April 26, 2022 |
*We will be in a silent period for 10 days ahead of the financial reporting.
Stay informed
Idorsia offers an electronic ‘Stay Informed’ service where subscribers can automatically receive updates via e-mail or SMS alert.
Social Media
Idorsia is active on social media – follow our channels to get a more personal view on the company.
Media center
Idorsia provides images, fact sheets and B-roll to download or support you with your article.
Contact
Andrew C. Weiss
Senior Vice President, Head of Investor Relations and Corporate Communications
Media Relations
Resources in German
Als schweizerisches Unternehmen stellen wir interessierten Personen auf dieser Seite wesentliche Informationen über unser Unternehmen in deutscher Sprache zur Verfügung.